神经节苷脂与苯巴比妥治疗新生儿缺血缺氧性脑病临床疗效对比

刘艳丽，苟超锋

（陇县妇幼保健院，陕西 宝鸡，721200）

浏览次数：114次 下载次数：510次

摘要：

目的 分析神经节苷脂与苯巴比妥治疗新生儿缺血缺氧性脑病（HIE）的临床疗效。方法 收集我院2011年3月至2016年3月收治的70例HIE 患儿，随机分为观察组和对照组，每组35例。在一般治疗基础上，观察组患儿给予单唾液酸四己糖神经节苷脂治疗，对照组患儿给予苯巴比妥治疗，比较两组患儿的治疗效果。结果 观察组患儿治疗总有效率为100.00%，高于对照组的71.43%，差异具有统计学意义（P<0.05）。治疗前，两组患儿的NBNA评分比较，无显著差异（P>0.05）；治疗后，两组患儿的NBNA评分均升高，且观察组患儿的NBNA评分高于对照组，差异均有统计学意义（P<0.05）。结论 单唾液酸四己糖神经节苷脂治疗HIE 的临床效果显著，治愈率高，安全、可靠，可有效改善患者的神经细胞受损情况，降低HIE的致残率，此方法可在临床推广使用。

关键词：神经节苷脂；苯巴比妥；新生儿缺血缺氧性脑病

中图分类号：R722.1文献标志码：A文章编号：2096-1413(2017)26-0054-02

Clinical effect comparison of ganglioside and phenobarbital on neonatal hypoxic-ischemic encephalopathy
LIU Yan-li, GOU Chao-feng
(Long County Maternal and Child Health Hospital, Baoji 721200, China)

ABSTRACT: Objective To evaluate the clinical effect of ganglioside and pheno barbital on neonatal hypoxic -ischemic encephalopathy (HIE). Methods A total of 70 cases of HIE children treated in our hospital from March 2011 to March 2016 were randomly divided into observation group and control group, with 35 cases in each group. On the basis of general treatment, the observation group was given monosialoglycans ganglioside treatment, while the control group received phenobarbital treatment. The therapeutic effects of the two groups were compared. Results The total effective rate was 100.00% in the observation group, which was higher than 71.43% in the control group, the difference was statistically significant (P<0.05). There was no significant difference in the NBNA score between the two groups before treatment (P>0.05); after treatment, the NBNA scores of both groups increased, the NBNA score in the observation group was higher than the control group, the differences were statistically significant (P<0.05). Conclusion Monosialoglycans ganglioside is effective and safe in the treatment of HIE, which can effectively improve the damage of nerve cells in the patient``s and reduce the disability rate, this method can be widely used in clinical practice.
KEYWORDS: gangliosides; phenobarbital; neonatal hypoxic-ischemic encephalopathy

参考文献：
[1] 李里,邓映英,欧海娟,等.应用神经节苷脂、苯巴比妥、东莨菪碱治疗中度新生儿缺氧缺血性脑病的对比研究[J].江西医药,2015,50(10):1073-1076.
[2] 欧海娟,李里,邓映英,等.苯巴比妥、东莨菪碱和神经节苷脂治疗新生儿缺氧缺血性脑病的临床疗效及护理效果[J].中国现代药物应用,2014,8(13):196-198.
[3] 余红胜,吉六舟,孙国运.新生儿缺氧缺血性脑病CT 诊断及预后探究[J].国际医学放射学杂志,2009,32(5):421-425.
[4] 李俊,陈丽霞,温晓芳,等.纳洛酮联合神经节苷脂治疗新生儿缺氧缺血性脑病的临床疗效观察[J].实用心脑肺血管病杂志,2014,22(10):69-70.
[5] 李硕.单唾液酸神经节苷脂注射液治疗新生儿缺氧缺血性脑病临床疗效及安全性[J].中国现代药物应用,2015,9(3):111-112.
[6] 谭强,王希斌.苯巴比妥联合神经节苷脂治疗新生儿缺氧缺血性脑病的临床观察[J].实用临床医药杂志,2012,16(13):82-84.
[7] 甄艳芬,周建清.苯巴比妥预防新生儿缺氧缺血性脑病惊厥作用观察[J].中华现代临床医学杂志,2006,4(5):108.
[8] FILIPPI L,MARCA GL,CAVALLARO G,et al.Phenobarbital for neonatal seizures in hypoxic ischemic encephalopathy: a pharmacokinetic study during whole body hypothermia [J].Epilepsia,2011,52 (4):794 -801.
[9] 王丽艳,王海艳.外源性单唾液酸四己糖神经节苷脂治疗新生儿缺氧缺血性脑病的临床疗效[J].中国妇幼保健,2015,30(25):4311-4312.
[10] 张玉兰.神经节苷脂、高压氧、亚低温治疗新生儿缺氧缺血性脑病的疗效观察[J].临床和实验医学杂志,2014,13(15):1265-1268.